Literature DB >> 25367850

Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF-MDM2-p53 pathway.

Yi Zhao1, Yun-hong Yao, Li Li, Wei-fang An, Hong-zen Chen, Li-ping Sun, Hai-xian Kang, Sen Wang, Xin-rong Hu.   

Abstract

Pokemon has been showed to directly suppress p14(ARF) expression and also to overexpress in multiple cancers. However, p14(ARF)-MDM2-p53 pathway is usually aberrant in colorectal cancer (CRC). The aim is to confirm whether Pokemon plays a role in CRC and explore whether Pokemon works through p14(ARF)-MDM2-p53 pathway in CRC. Immunohistochemistry for Pokemon, p14(ARF) and Mtp53 protein was applied to 45 colorectal epitheliums (CREs), 42 colorectal adenomas (CRAs) and 66 CRCs. Pokemon was knocked down with RNAi technique in CRC cell line Lovo to detect mRNA expression of p14(ARF) with qRT-PCR, cell proliferation with CCK8 assay, and cell cycle and apoptosis with flowcytometry analysis. The protein expression rates were significantly higher in CRC (75.8%) than in CRE (22.2 %) or CRA (38.1%) for Pokemon and higher in CRC (53.0%) than in CRE (0) or CRA (4.8%) for Mtp53, but not significantly different in CRC (86.4 %) versus CRE (93.3%) or CRA (90.5 %) for p14(ARF). Higher expression rate of Pokemon was associated with lymph node metastasis and higher Duke's stage. After knockdown of Pokemon in Lovo cells, the mRNA level of p14(ARF) was not significantly changed, the cell proliferation ability was decreased by 20.6%, cell cycle was arrested by 55.7% in G0/G1 phase, and apoptosis rate was increased by 19.0%. Pokemon enhanced the oncogenesis of CRC by promoting proliferation, cell cycle progression and anti-apoptosis activity of CRC cells independently of p14(ARF)-MDM2-p53 pathway. This finding provided a novel idea for understanding and further studying the molecular mechanism of Pokemon on carcinogenesis of CRC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25367850     DOI: 10.1007/s12032-014-0288-x

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  23 in total

1.  Expression of the proto-oncogene Pokemon in colorectal cancer--inhibitory effects of an siRNA.

Authors:  Gan-Ting Zhao; Li-Juan Yang; Xi-Xia Li; Hui-Lin Cui; Rui Guo
Journal:  Asian Pac J Cancer Prev       Date:  2013

Review 2.  The transcription factor Pokemon: a new key player in cancer pathogenesis.

Authors:  Takahiro Maeda; Robin M Hobbs; Pier Paolo Pandolfi
Journal:  Cancer Res       Date:  2005-10-01       Impact factor: 12.701

3.  Tumor-specific RNA interference targeting Pokemon suppresses tumor growth and induces apoptosis in prostate cancer.

Authors:  Yining Li; Shuxiong Xu; Xiangwei Wang; Hua Shi; Zhaolin Sun; Zhao Yang
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

4.  EIF4E over-expresses and enhances cell proliferation and cell cycle progression in nasopharyngeal carcinoma.

Authors:  Mengyan Wu; Yingxia Liu; Xiaoqing Di; Haixian Kang; Hua Zeng; Yi Zhao; Kangrong Cai; Tianyun Pang; Sen Wang; Yunhong Yao; Xinrong Hu
Journal:  Med Oncol       Date:  2013-01-01       Impact factor: 3.064

5.  Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2.

Authors:  Masatsugu Tachibana; Hitoshi Kawamata; Takahiro Fujimori; Fumie Omotehara; Hideki Horiuchi; Yasuo Ohkura; Seiji Igarashi; Kenjiro Kotake; Keiichi Kubota
Journal:  Int J Oncol       Date:  2004-10       Impact factor: 5.650

6.  Essential role of Plzf in maintenance of spermatogonial stem cells.

Authors:  José A Costoya; Robin M Hobbs; Maria Barna; Giorgio Cattoretti; Katia Manova; Meena Sukhwani; Kyle E Orwig; Debra J Wolgemuth; Pier Paolo Pandolfi
Journal:  Nat Genet       Date:  2004-05-23       Impact factor: 38.330

7.  Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.

Authors:  K Apostolopoulou; I S Pateras; K Evangelou; P K Tsantoulis; M Liontos; C Kittas; D G Tiniakos; A Kotsinas; C Cordon-Cardo; V G Gorgoulis
Journal:  J Pathol       Date:  2007-11       Impact factor: 7.996

8.  Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Authors:  Zhi-Hong Zhao; Sheng-Fa Wang; Liang Yu; Ju Wang; Hao Chang; Wei-Li Yan; Jian Zhang; Kai Fu
Journal:  Lung Cancer       Date:  2008-06-11       Impact factor: 5.705

9.  Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression.

Authors:  Xuyu Zu; Jun Ma; Hongxia Liu; Feng Liu; Chunyan Tan; Lingling Yu; Jue Wang; Zhenhua Xie; Deliang Cao; Yuyang Jiang
Journal:  Breast Cancer Res       Date:  2011-03-10       Impact factor: 6.466

10.  Biological significance of promoter hypermethylation of p14/ARF gene: relationships to p53 mutational status in Tunisian population with colorectal carcinoma.

Authors:  Ines Chaar; Sameh Amara; Olfa Elhadj Elamine; Mariem Khiari; Donia Ounissi; Taher Khalfallah; Abdelmajid Ben Hmida; Sabeh Mzabi; Saadia Bouraoui
Journal:  Tumour Biol       Date:  2013-09-25
View more
  4 in total

1.  Negative feedback loop between ZBTB7A and TGF-β in breast cancer.

Authors:  Yingying Shen; Renxian Cao; Wen Liu; Yuqing Zhou; Ying Wu; Jingjing Tan; Min Jin; Jing Zhong; Qinghai Zhang; Jianghua Liu; Xuyu Zu
Journal:  Oncol Lett       Date:  2017-06-01       Impact factor: 2.967

2.  Prognostic value of nuclear FBI-1 in patients with rectal cancer with or without preoperative radiotherapy.

Authors:  Chao-Jie Wang; Chu-Rui Chao; Hui-Min Liu; Yan-Yan Zhu; Gunnar Adell; Ingvar Jarlsfelt; Hong Zhang; Xiao-Feng Sun
Journal:  Oncol Lett       Date:  2019-09-19       Impact factor: 2.967

3.  ZBTB7A functioned as an oncogene in colorectal cancer.

Authors:  Li Wang; Meng-Xia Zhang; Mei-Fang Zhang; Zi-Wei Tu
Journal:  BMC Gastroenterol       Date:  2020-11-09       Impact factor: 3.067

Review 4.  The multi-faceted functioning portrait of LRF/ZBTB7A.

Authors:  Caterina Constantinou; Magda Spella; Vasiliki Chondrou; George P Patrinos; Adamantia Papachatzopoulou; Argyro Sgourou
Journal:  Hum Genomics       Date:  2019-12-10       Impact factor: 4.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.